THU-198-Efficacy and safety of glecaprevir/pibrentasvir treatment for 8 weeks in treatment-naive patients with chronic hepatitis C virus infection without cirrhosis or with compensated cirrhosis: Analysis of data pooled from phase 2 and 3 studies

Compensated Cirrhosis ◽

Treatment Naïve

951 – Efficacy and Safety of Glecaprevir/Pibrentasvir Treatment for 8 Weeks in Treatment-Naïve Patients with Chronic Hepatitis C Virus Infection Without Cirrhosis Or with Compensated Cirrhosis: Analysis of Data Pooled from Phase 2 and 3 Studies

Gastroenterology ◽

10.1016/s0016-5085(19)40030-9 ◽

2019 ◽

Vol 156 (6) ◽

pp. S-1218

Author(s):

Julio Gutierrez ◽

Eli Zuckerman ◽

Andrew Ustianowski ◽

Susanna Naggie ◽

Florin Caruntu ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Virus Infection ◽

Phase 2 ◽

Efficacy And Safety ◽

Compensated Cirrhosis ◽

Treatment Naïve

Faculty Opinions recommendation of Efficacy and safety of faldaprevir, deleobuvir, and ribavirin in treatment-naive patients with chronic hepatitis C virus infection and advanced liver fibrosis or cirrhosis.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725275636.793502522 ◽

2014 ◽

Author(s):

Philip Rosenthal

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Liver Fibrosis ◽

Virus Infection ◽

Efficacy And Safety ◽

Advanced Liver Fibrosis ◽

Treatment Naïve

Efficacy and safety of ombitasvir/paritaprevir/ritonavir and dasabuvir with ribavirin in Asian patients with genotype 1b chronic hepatitis C virus infection and compensated cirrhosis: ONYX-II post-treatment week 24 results

Journal of Hepatology ◽

10.1016/s0168-8278(17)31466-6 ◽

2017 ◽

Vol 66 (1) ◽

pp. S532

Author(s):

L. Wei ◽

G.-Q. Wang ◽

Y. Luo ◽

C.-J. Chu ◽

S.W. Paik ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Virus Infection ◽

Chronic Hepatitis C ◽

Efficacy And Safety ◽

Asian Patients ◽

Compensated Cirrhosis ◽

Faculty Opinions recommendation of Review article: the efficacy and safety of daclatasvir in the treatment of chronic hepatitis C virus infection.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725516866.793507126 ◽

2015 ◽

Author(s):

Philip Rosenthal

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Virus Infection ◽

Chronic Hepatitis C ◽

Review Article ◽

Efficacy And Safety ◽

Efficacy and safety of glecaprevir and pibrentasvir combination therapy in old-aged patients with chronic hepatitis C virus infection

Journal of Rural Medicine ◽

10.2185/jrm.2020-004 ◽

2020 ◽

Vol 15 (4) ◽

pp. 139-145

Author(s):

Shunji Watanabe ◽

Naoki Morimoto ◽

Kouichi Miura ◽

Toshimitsu Murohisa ◽

Toshiyuki Tahara ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Virus Infection ◽

Combination Therapy ◽

Chronic Hepatitis C ◽

Efficacy And Safety ◽

Aged Patients ◽

Efficacy and Safety of Ombitasvir, Paritaprevir, and Ritonavir in an Open-Label Study of Patients With Genotype 1b Chronic Hepatitis C Virus Infection With and Without Cirrhosis

Gastroenterology ◽

10.1053/j.gastro.2015.07.001 ◽

2015 ◽

Vol 149 (4) ◽

pp. 971-980.e1 ◽

Cited By ~ 59

Author(s):

Eric Lawitz ◽

Mihály Makara ◽

Ulus Salih Akarca ◽

Paul J. Thuluvath ◽

Liliana Lucia Preotescu ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Virus Infection ◽

Efficacy And Safety ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Efficacy and safety of ombitasvir/paritaprevir/ritonavir ± dasabuvir with ribavirin in adults with genotype 1 or genotype 4 chronic hepatitis C virus infection and child-pugh B decompensated cirrhosis

Journal of Hepatology ◽

10.1016/s0168-8278(17)31945-1 ◽

2017 ◽

Vol 66 (1) ◽

pp. S728-S729 ◽

Cited By ~ 1

Author(s):

P. Mantry ◽

R. Reddy ◽

E. Cohen ◽

G. Everson ◽

A. Ramji ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Virus Infection ◽

Decompensated Cirrhosis ◽

Efficacy And Safety ◽

Genotype 1 ◽

Genotype 4 ◽

DI-039 Evaluation of the efficacy and safety of short-term boceprevir and telaprevir in the treatment of chronic hepatitis C virus infection

European Journal of Hospital Pharmacy ◽

10.1136/ejhpharm-2013-000436.210 ◽

2014 ◽

Vol 21 (Suppl 1) ◽

pp. A86.1-A86

Author(s):

O Garcia Molina ◽

F Mendoza Otero ◽

MA Fernandez de Palencia Espinosa ◽

MM Galindo Rueda ◽

J Velasco Costa ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Virus Infection ◽

Chronic Hepatitis C ◽

Efficacy And Safety ◽

Short Term ◽

Ombitasvir plus paritaprevir plus ritonavir with or without ribavirin in treatment-naive and treatment-experienced patients with genotype 4 chronic hepatitis C virus infection (PEARL-I): a randomised, open-label trial

The Lancet ◽

10.1016/s0140-6736(15)60159-3 ◽

2015 ◽

Vol 385 (9986) ◽

pp. 2502-2509 ◽

Cited By ~ 187

Author(s):

Christophe Hézode ◽

Tarik Asselah ◽

K Rajender Reddy ◽

Tarek Hassanein ◽

Marina Berenguer ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Virus Infection ◽

Open Label ◽

Genotype 4 ◽

Treatment Naïve ◽

Open Label Trial

Efficacy and safety of Chlorella supplementation in adults with chronic hepatitis C virus infection

World Journal of Gastroenterology ◽

10.3748/wjg.v19.i7.1085 ◽

2013 ◽

Vol 19 (7) ◽

pp. 1085 ◽

Cited By ~ 8

Author(s):

Jose Azocar

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Virus Infection ◽

Chronic Hepatitis C ◽

Efficacy And Safety ◽